{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:17:48Z","timestamp":1769311068875,"version":"3.49.0"},"reference-count":137,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Dixon Family Foundation"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The emergence and worldwide spread of SARS-CoV-2 during the COVID-19 pandemic necessitated the adaptation and rapid deployment of viral WGS and analysis techniques that had been previously applied on a more limited basis to other viral pathogens, such as HIV and influenza viruses. The need for WGS was driven in part by the low mutation rate of SARS-CoV-2, which necessitated measuring variation along the entire genome sequence to effectively differentiate lineages and characterize viral evolution. Several WGS approaches designed to maximize throughput and accuracy were quickly adopted by surveillance labs around the world. These broad-based SARS-CoV-2 genomic sequencing efforts revealed ongoing evolution of the virus, highlighted by the successive emergence of new viral variants throughout the course of the pandemic. These genomic insights were instrumental in characterizing the effects of viral mutations on transmissibility, immune escape and viral tropism, which in turn helped guide public health policy, the use of monoclonal antibody therapeutics and vaccine development strategies. As the use of direct-acting antivirals for the treatment of COVID-19 became more widespread, the potential for emergence of antiviral resistance has driven ongoing efforts to delineate resistance mutations and to monitor global sequence databases for their emergence. Given the critical role of viral genomics in the international effort to combat the COVID-19 pandemic, coordinated efforts should be made to expand global genomic surveillance capacity and infrastructure towards the anticipation and prevention of future pandemics.<\/jats:p>","DOI":"10.1093\/jac\/dkad309","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T22:11:22Z","timestamp":1700777482000},"page":"ii25-ii36","source":"Crossref","is-referenced-by-count":12,"title":["SARS-CoV-2 genomics and impact on clinical care for COVID-19"],"prefix":"10.1093","volume":"78","author":[{"given":"Ramon","family":"Lorenzo-Redondo","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"},{"name":"Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health , Chicago, IL 60611 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Machado","family":"de Sant\u2019Anna Carvalho","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"},{"name":"Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health , Chicago, IL 60611 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judd F","family":"Hultquist","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"},{"name":"Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health , Chicago, IL 60611 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-3691","authenticated-orcid":false,"given":"Egon A","family":"Ozer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"},{"name":"Center for Pathogen Genomics and Microbial Evolution, Northwestern University Havey Institute for Global Health , Chicago, IL 60611 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"2023112322101831600_dkad309-B1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chom.2018.03.012","article-title":"Mapping the evolutionary potential of RNA viruses","volume":"23","author":"Dolan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"2023112322101831600_dkad309-B2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-virology-101416-041718","article-title":"Mechanisms and concepts in RNA virus population dynamics and evolution","volume":"5","author":"Dolan","year":"2018","journal-title":"Annu Rev Virol"},{"key":"2023112322101831600_dkad309-B3","doi-asserted-by":"crossref","first-page":"e3000003","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"Duffy","year":"2018","journal-title":"PLoS Biol"},{"key":"2023112322101831600_dkad309-B4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrmicro3003","article-title":"The role of mutational robustness in RNA virus evolution","volume":"11","author":"Lauring","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"2023112322101831600_dkad309-B5","doi-asserted-by":"crossref","first-page":"e1002685","DOI":"10.1371\/journal.ppat.1002685","article-title":"From molecular genetics to phylodynamics: evolutionary relevance of mutation rates across viruses","volume":"8","author":"Sanjuan","year":"2012","journal-title":"PLoS Pathog"},{"key":"2023112322101831600_dkad309-B6","doi-asserted-by":"crossref","first-page":"e01031-17","DOI":"10.1128\/JVI.01031-17","article-title":"Complexities of viral mutation rates","volume":"92","author":"Peck","year":"2018","journal-title":"J Virol"},{"key":"2023112322101831600_dkad309-B7","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1007\/s00018-016-2299-6","article-title":"Mechanisms of viral mutation","volume":"73","author":"Sanjuan","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2023112322101831600_dkad309-B8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"2023112322101831600_dkad309-B9","doi-asserted-by":"crossref","first-page":"e1008271","DOI":"10.1371\/journal.pgen.1008271","article-title":"Viral quasispecies","volume":"15","author":"Domingo","year":"2019","journal-title":"PLoS Genet"},{"key":"2023112322101831600_dkad309-B10","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1128\/JVI.78.4.2114-2120.2004","article-title":"Evolutionary potential of an RNA virus","volume":"78","author":"Makeyev","year":"2004","journal-title":"J Virol"},{"key":"2023112322101831600_dkad309-B11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-virology-100114-055135","article-title":"Matters of size: genetic bottlenecks in virus infection and their potential impact on evolution","volume":"2","author":"Zwart","year":"2015","journal-title":"Annu Rev Virol"},{"key":"2023112322101831600_dkad309-B12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.coviro.2012.08.001","article-title":"Virus population bottlenecks during within-host progression and host-to-host transmission","volume":"2","author":"Gutierrez","year":"2012","journal-title":"Curr Opin Virol"},{"key":"2023112322101831600_dkad309-B13","doi-asserted-by":"crossref","first-page":"iyac127","DOI":"10.1093\/genetics\/iyac127","article-title":"Heterogeneity in viral populations increases the rate of deleterious mutation accumulation","volume":"222","author":"Allman","year":"2022","journal-title":"Genetics"},{"key":"2023112322101831600_dkad309-B14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/JVI.01254-10","article-title":"Dynamics of in vitro fitness recovery of HIV-1","volume":"85","author":"Lorenzo-Redondo","year":"2011","journal-title":"J Virol"},{"key":"2023112322101831600_dkad309-B15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.ecolsys.38.091206.095637","article-title":"Virus evolution: insights from an experimental approach","volume":"38","author":"Elena","year":"2007","journal-title":"Annu Rev Ecol Evol Syst"},{"key":"2023112322101831600_dkad309-B16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.pt.2021.08.007","article-title":"Progress and challenges in virus genomic epidemiology","volume":"37","author":"Hill","year":"2021","journal-title":"Trends Parasitol"},{"key":"2023112322101831600_dkad309-B17","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41591-021-01472-w","article-title":"The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology","volume":"27","author":"Oude Munnink","year":"2021","journal-title":"Nat Med"},{"key":"2023112322101831600_dkad309-B18","first-page":"125","article-title":"HIV evolutionary dynamics within and among hosts","volume":"8","author":"Lemey","year":"2006","journal-title":"AIDS Rev"},{"key":"2023112322101831600_dkad309-B19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature14460","article-title":"Global circulation patterns of seasonal influenza viruses vary with antigenic drift","volume":"523","author":"Bedford","year":"2015","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1126\/science.abc8169","article-title":"The emergence of SARS-CoV-2 in Europe and North America","volume":"370","author":"Worobey","year":"2020","journal-title":"Science"},{"key":"2023112322101831600_dkad309-B21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.abc1917","article-title":"Introductions and early spread of SARS-CoV-2 in the New York city area","volume":"369","author":"Gonzalez-Reiche","year":"2020","journal-title":"Science"},{"key":"2023112322101831600_dkad309-B22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat Microbiol"},{"key":"2023112322101831600_dkad309-B23","doi-asserted-by":"crossref","first-page":"24614","DOI":"10.1073\/pnas.2017726117","article-title":"Low genetic diversity may be an Achilles heel of SARS-CoV-2","volume":"117","author":"Rausch","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023112322101831600_dkad309-B24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2023112322101831600_dkad309-B26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nprot.2017.066","article-title":"Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples","volume":"12","author":"Quick","year":"2017","journal-title":"Nat Protoc"},{"key":"2023112322101831600_dkad309-B27","doi-asserted-by":"crossref","first-page":"e0180321","DOI":"10.1128\/Spectrum.01803-21","article-title":"Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein","volume":"9","author":"Davis","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2023112322101831600_dkad309-B28","doi-asserted-by":"crossref","first-page":"836728","DOI":"10.3389\/fmed.2022.836728","article-title":"Optimization of the SARS-CoV-2 ARTIC network V4 primers and whole genome sequencing protocol","volume":"9","author":"Lambisia","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2023112322101831600_dkad309-B29","doi-asserted-by":"crossref","first-page":"840952","DOI":"10.3389\/fviro.2022.840952","article-title":"Investigating the extent of primer dropout in SARS-CoV-2 genome sequences during the early circulation of Delta variants","volume":"2","author":"Borcard","year":"2022","journal-title":"Front Virol"},{"key":"2023112322101831600_dkad309-B30","doi-asserted-by":"crossref","first-page":"bpaa014","DOI":"10.1093\/biomethods\/bpaa014","article-title":"Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding","volume":"5","author":"Freed","year":"2020","journal-title":"Biol Methods Protoc"},{"key":"2023112322101831600_dkad309-B31","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/microorganisms9122598","article-title":"Simplified point-of-care full SARS-CoV-2 genome sequencing using nanopore technology","volume":"9","author":"Pembaur","year":"2021","journal-title":"Microorganisms"},{"key":"2023112322101831600_dkad309-B32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13073-020-00751-4","article-title":"Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples","volume":"12","author":"Xiao","year":"2020","journal-title":"Genome Med"},{"key":"2023112322101831600_dkad309-B33","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/jmv.26116","article-title":"High-coverage SARS-CoV-2 genome sequences acquired by target capture sequencing","volume":"92","author":"Wen","year":"2020","journal-title":"J Med Virol"},{"key":"2023112322101831600_dkad309-B34","doi-asserted-by":"crossref","first-page":"e0019721","DOI":"10.1128\/Spectrum.00197-21","article-title":"Targeted hybridization capture of SARS-CoV-2 and metagenomics enables genetic variant discovery and nasal microbiome insights","volume":"9","author":"Nagy-Szakal","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2023112322101831600_dkad309-B35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cell.2020.04.021","article-title":"Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States","volume":"181","author":"Fauver","year":"2020","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B37","doi-asserted-by":"crossref","first-page":"103112","DOI":"10.1016\/j.ebiom.2020.103112","article-title":"A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways","volume":"62","author":"Lorenzo-Redondo","year":"2020","journal-title":"EBioMedicine"},{"key":"2023112322101831600_dkad309-B38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coviro.2021.08.010","article-title":"Structure of SARS-CoV-2 spike protein","volume":"50","author":"Zhang","year":"2021","journal-title":"Curr Opin Virol"},{"key":"2023112322101831600_dkad309-B40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.abf2303","article-title":"Structural impact on SARS-CoV-2 spike protein by D614G substitution","volume":"372","author":"Zhang","year":"2021","journal-title":"Science"},{"key":"2023112322101831600_dkad309-B42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B43","author":"Public Health England"},{"key":"2023112322101831600_dkad309-B44","author":"Rambaut"},{"key":"2023112322101831600_dkad309-B45","author":"Public Health England"},{"key":"2023112322101831600_dkad309-B46","author":"Technical Advisory Group on SARS-CoV-2 Virus Evolution"},{"key":"2023112322101831600_dkad309-B47","author":"World Health Organization"},{"key":"2023112322101831600_dkad309-B48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B49","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/microorganisms9071542","article-title":"SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India","volume":"9","author":"Cherian","year":"2021","journal-title":"Microorganisms"},{"key":"2023112322101831600_dkad309-B50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B51","first-page":"815","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume-title":"Science","author":"Faria","year":"2021"},{"key":"2023112322101831600_dkad309-B52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"2023112322101831600_dkad309-B53","doi-asserted-by":"crossref","first-page":"e70658","DOI":"10.7554\/eLife.70658","article-title":"Effects of common mutations in the SARS-CoV-2 spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics","volume":"10","author":"Barton","year":"2021","journal-title":"Elife"},{"key":"2023112322101831600_dkad309-B54","doi-asserted-by":"crossref","first-page":"e69091","DOI":"10.7554\/eLife.69091","article-title":"N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2","volume":"10","author":"Tian","year":"2021","journal-title":"Elife"},{"key":"2023112322101831600_dkad309-B55","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/v13040633","article-title":"The impact on infectivity and neutralization efficiency of SARS-CoV-2 lineage B.1.351 pseudovirus","volume":"13","author":"Kim","year":"2021","journal-title":"Viruses"},{"key":"2023112322101831600_dkad309-B56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat Med"},{"key":"2023112322101831600_dkad309-B59","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B60","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cell.2021.02.042","article-title":"SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B61","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2021.05.005","article-title":"Tackling COVID-19 with neutralizing monoclonal antibodies","volume":"184","author":"Corti","year":"2021","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B62","author":"Zhou"},{"key":"2023112322101831600_dkad309-B63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2023112322101831600_dkad309-B64","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/v13091693","article-title":"Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K\/E484Q","volume":"13","author":"Wilhelm","year":"2021","journal-title":"Viruses"},{"key":"2023112322101831600_dkad309-B65","doi-asserted-by":"crossref","first-page":"1919285","DOI":"10.1080\/19420862.2021.1919285","article-title":"501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro","volume":"13","author":"Liu","year":"2021","journal-title":"MAbs"},{"key":"2023112322101831600_dkad309-B66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B67","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41564-022-01254-1","article-title":"Emergence of SARS-CoV-2 escape mutations during bamlanivimab therapy in a phase II randomized clinical trial","volume":"7","author":"Choudhary","year":"2022","journal-title":"Nat Microbiol"},{"key":"2023112322101831600_dkad309-B68","doi-asserted-by":"crossref","first-page":"e166032","DOI":"10.1172\/JCI166032","article-title":"Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments","volume":"133","author":"Gupta","year":"2023","journal-title":"J Clin Invest"},{"key":"2023112322101831600_dkad309-B69","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/S2666-5247(21)00189-0","article-title":"Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19","volume":"2","author":"Destras","year":"2021","journal-title":"Lancet Microbe"},{"key":"2023112322101831600_dkad309-B70","doi-asserted-by":"crossref","first-page":"e13914","DOI":"10.1111\/tid.13914","article-title":"De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients","volume":"24","author":"Simons","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"2023112322101831600_dkad309-B71","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"2023112322101831600_dkad309-B72","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1038\/s41467-021-26602-3","article-title":"Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants","volume":"12","author":"Weigang","year":"2021","journal-title":"Nat Commun"},{"key":"2023112322101831600_dkad309-B73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41588-022-01033-y","article-title":"Global landscape of SARS-CoV-2 genomic surveillance and data sharing","volume":"54","author":"Chen","year":"2022","journal-title":"Nat Genet"},{"key":"2023112322101831600_dkad309-B74","author":"Cavazzoni"},{"key":"2023112322101831600_dkad309-B75","doi-asserted-by":"crossref","first-page":"e0085921","DOI":"10.1128\/JCM.00859-21","article-title":"Multiplex SARS-CoV-2 genotyping reverse transcriptase PCR for population-level variant screening and epidemiologic surveillance","volume":"59","author":"Wang","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2023112322101831600_dkad309-B76","doi-asserted-by":"crossref","first-page":"e3001236","DOI":"10.1371\/journal.pbio.3001236","article-title":"Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2","volume":"19","author":"Vogels","year":"2021","journal-title":"PLoS Biol"},{"key":"2023112322101831600_dkad309-B77","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jiab082","article-title":"S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral load in samples tested by TaqPath polymerase chain reaction","volume":"223","author":"Kidd","year":"2021","journal-title":"J Infect Dis"},{"key":"2023112322101831600_dkad309-B78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15585\/mmwr.mm7003e2","article-title":"Emergence of SARS-CoV-2 B.1.1.7 lineage\u2014United States, December 29, 2020-January 12, 2021","volume":"70","author":"Galloway","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023112322101831600_dkad309-B79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B80","author":"World Health Organization"},{"key":"2023112322101831600_dkad309-B81","doi-asserted-by":"crossref","first-page":"eabo5395","DOI":"10.1126\/scitranslmed.abo5395","article-title":"The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England","volume":"14","author":"Paton","year":"2022","journal-title":"Sci Transl Med"},{"key":"2023112322101831600_dkad309-B82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants\u2014United States, June 2021-January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023112322101831600_dkad309-B83","doi-asserted-by":"crossref","first-page":"e35763","DOI":"10.2196\/35763","article-title":"Has Omicron changed the evolution of the pandemic?","volume":"8","author":"Lundberg","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"2023112322101831600_dkad309-B84","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41591-021-01678-y","article-title":"An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies","volume":"28","author":"VanBlargan","year":"2022","journal-title":"Nat Med"},{"key":"2023112322101831600_dkad309-B85","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/v14061334","article-title":"Resistance of SARS-CoV-2 omicron BA.1 and BA.2 variants to vaccine-elicited sera and therapeutic monoclonal antibodies","volume":"14","author":"Zhou","year":"2022","journal-title":"Viruses"},{"key":"2023112322101831600_dkad309-B86","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41591-022-01792-5","article-title":"Serum neutralization of SARS-CoV-2 omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies","volume":"28","author":"Bruel","year":"2022","journal-title":"Nat Med"},{"key":"2023112322101831600_dkad309-B87","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"key":"2023112322101831600_dkad309-B88","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa","volume":"386","author":"Collie","year":"2022","journal-title":"N Engl J Med"},{"key":"2023112322101831600_dkad309-B89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","article-title":"Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance\u2014VISION network, 10 states, August 2021-January 2022","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023112322101831600_dkad309-B90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B91","doi-asserted-by":"crossref","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science"},{"key":"2023112322101831600_dkad309-B92","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"2023112322101831600_dkad309-B93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","article-title":"Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods\u2014United States, December 2020-January 2022","volume":"71","author":"Iuliano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023112322101831600_dkad309-B94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"2023112322101831600_dkad309-B95","doi-asserted-by":"crossref","first-page":"e070695","DOI":"10.1136\/bmj-2022-070695","article-title":"Risk of COVID-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study","volume":"378","author":"Ward","year":"2022","journal-title":"BMJ"},{"key":"2023112322101831600_dkad309-B96","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/s41467-022-31402-4","article-title":"COVID-19 disease severity in US veterans infected during Omicron and Delta variant predominant periods","volume":"13","author":"Mayr","year":"2022","journal-title":"Nat Commun"},{"key":"2023112322101831600_dkad309-B97","doi-asserted-by":"crossref","first-page":"2200396","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200396","article-title":"SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022","volume":"27","author":"Sievers","year":"2022","journal-title":"Euro Surveill"},{"key":"2023112322101831600_dkad309-B98","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"2023112322101831600_dkad309-B99","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","article-title":"SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells","volume":"11","author":"Zhao","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2023112322101831600_dkad309-B101","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B102","author":"World Health Organization"},{"key":"2023112322101831600_dkad309-B103","doi-asserted-by":"crossref","first-page":"e61312","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife"},{"key":"2023112322101831600_dkad309-B104","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-022-28768-w","article-title":"Evolution of the SARS-CoV-2 spike protein in the human host","volume":"13","author":"Wrobel","year":"2022","journal-title":"Nat Commun"},{"key":"2023112322101831600_dkad309-B105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/v13050751","article-title":"Within-host and between-host evolution in SARS-CoV-2-new variant\u2019s source","volume":"13","author":"Moelling","year":"2021","journal-title":"Viruses"},{"key":"2023112322101831600_dkad309-B106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","article-title":"SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape","volume":"30","author":"Cele","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2023112322101831600_dkad309-B107","doi-asserted-by":"crossref","first-page":"veab078","DOI":"10.1093\/ve\/veab078","article-title":"Intra-host evolution during SARS-CoV-2 prolonged infection","volume":"7","author":"Voloch","year":"2021","journal-title":"Virus Evol"},{"key":"2023112322101831600_dkad309-B108","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"2023112322101831600_dkad309-B109","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J Biol Chem"},{"key":"2023112322101831600_dkad309-B110","doi-asserted-by":"crossref","first-page":"e0019822","DOI":"10.1128\/aac.00198-22","article-title":"In vitro selection of remdesivir-resistant SARS-CoV-2 demonstrates high barrier to resistance","volume":"66","author":"Checkmahomed","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112322101831600_dkad309-B111","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat Commun"},{"key":"2023112322101831600_dkad309-B112","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023112322101831600_dkad309-B113","doi-asserted-by":"crossref","first-page":"105247","DOI":"10.1016\/j.antiviral.2022.105247","article-title":"Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: a GISAID exploratory analysis","volume":"198","author":"Focosi","year":"2022","journal-title":"Antiviral Res"},{"key":"2023112322101831600_dkad309-B114","doi-asserted-by":"crossref","first-page":"e0261045","DOI":"10.1371\/journal.pone.0261045","article-title":"Coronavirus resistance database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons","volume":"17","author":"Tzou","year":"2022","journal-title":"PLoS One"},{"key":"2023112322101831600_dkad309-B115","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/v14122714","article-title":"Viralvar: a web tool for multilevel visualization of SARS-CoV-2 genomes","volume":"14","author":"Alisoltani","year":"2022","journal-title":"Viruses"},{"key":"2023112322101831600_dkad309-B116","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"2023112322101831600_dkad309-B117","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1039\/D1MD00247C","article-title":"Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Bai","year":"2021","journal-title":"RSC Med Chem"},{"key":"2023112322101831600_dkad309-B118","doi-asserted-by":"crossref","first-page":"e0281522","DOI":"10.1128\/mbio.02815-22","article-title":"The substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir","volume":"14","author":"Jochmans","year":"2023","journal-title":"mBio"},{"key":"2023112322101831600_dkad309-B119","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B120","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent Sci"},{"key":"2023112322101831600_dkad309-B121","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template","volume":"297","author":"Gordon","year":"2021","journal-title":"J Biol Chem"},{"key":"2023112322101831600_dkad309-B122","author":"Sanderson"},{"key":"2023112322101831600_dkad309-B123","doi-asserted-by":"crossref","first-page":"e01348-19","DOI":"10.1128\/JVI.01348-19","article-title":"Small-molecule antiviral beta-d-N(4)-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J Virol"},{"key":"2023112322101831600_dkad309-B124","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"2023112322101831600_dkad309-B125","doi-asserted-by":"crossref","first-page":"e28621","DOI":"10.1002\/jmv.28621","article-title":"Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: a systematic review and meta-analysis of randomized control trials","volume":"95","author":"Huang","year":"2023","journal-title":"J Med Virol"},{"key":"2023112322101831600_dkad309-B126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(85)90303-4","article-title":"Nucleotide sequence of the AIDS virus, LAV","volume":"40","author":"Wain-Hobson","year":"1985","journal-title":"Cell"},{"key":"2023112322101831600_dkad309-B127","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/313277a0","article-title":"Complete nucleotide sequence of the AIDS virus, HTLV-III","volume":"313","author":"Ratner","year":"1985","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B128","doi-asserted-by":"crossref","first-page":"19759","DOI":"10.7448\/IAS.17.4.19759","article-title":"Early clinical response and presence of viral resistant minority variants: a proof of concept study","volume":"17","author":"Callegaro","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2023112322101831600_dkad309-B129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e328356e9da","article-title":"Next-generation sequencing to assess HIV tropism","volume":"7","author":"Swenson","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"2023112322101831600_dkad309-B130","doi-asserted-by":"crossref","first-page":"e0141723","DOI":"10.1371\/journal.pone.0141723","article-title":"Utility of metagenomic next-generation sequencing for characterization of HIV and human pegivirus diversity","volume":"10","author":"Luk","year":"2015","journal-title":"PLoS One"},{"key":"2023112322101831600_dkad309-B131","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04239","article-title":"Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution","volume":"437","author":"Ghedin","year":"2005","journal-title":"Nature"},{"key":"2023112322101831600_dkad309-B132","doi-asserted-by":"crossref","first-page":"30473","DOI":"10.2807\/1560-7917.ES.2017.22.9.30473","article-title":"Emerging highly pathogenic H5 avian influenza viruses in France during winter 2015\/16: phylogenetic analyses and markers for zoonotic potential","volume":"22","author":"Briand","year":"2017","journal-title":"Euro Surveill"},{"key":"2023112322101831600_dkad309-B133","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/infdis\/jiy335","article-title":"Use of whole-genome sequencing in the investigation of a nosocomial influenza virus outbreak","volume":"218","author":"Houlihan","year":"2018","journal-title":"J Infect Dis"},{"key":"2023112322101831600_dkad309-B134","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid2403.171499","article-title":"Use of genome sequencing to define institutional influenza outbreaks, Toronto, Ontario, Canada, 2014-15","volume":"24","author":"MacFadden","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2023112322101831600_dkad309-B135","doi-asserted-by":"crossref","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: global initiative on sharing all influenza data\u2014from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"2023112322101831600_dkad309-B136","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.3201\/eid2813.220780","article-title":"Determining gaps in publicly shared SARS-CoV-2 genomic surveillance data by analysis of global submissions","volume":"28","author":"Ohlsen","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2023112322101831600_dkad309-B137","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/v14112532","article-title":"Challenges and opportunities for global genomic surveillance strategies in the COVID-19 era","volume":"14","author":"Ling-Hu","year":"2022","journal-title":"Viruses"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/Supplement_2\/ii25\/53710308\/dkad309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/Supplement_2\/ii25\/53710308\/dkad309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T22:12:17Z","timestamp":1700777537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/78\/Supplement_2\/ii25\/7444808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":137,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2023,11,23]]},"published-print":{"date-parts":[[2023,11,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkad309","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,11]]}}}